JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: a clinico-radiological diagnosis

Clin Neurol Neurosurg. 2013 Jun;115(6):827-9. doi: 10.1016/j.clineuro.2012.08.013. Epub 2012 Aug 21.

Authors

Maria Travasarou¹, Stella Marousi, Eleni Papageorgiou, Clementine E Karageorgiou

Affiliation

¹ Dept. of Neurology, G. Gennimatas General Hospital of Athens, 154 Mesogeion Ave, 11527 Athens, Greece. [email protected]

PMID: 22920632
DOI: 10.1016/j.clineuro.2012.08.013

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use
DNA, Viral / cerebrospinal fluid
Female
Gait Disorders, Neurologic / chemically induced
Humans
JC Virus* / genetics
Leukoencephalopathy, Progressive Multifocal / chemically induced*
Leukoencephalopathy, Progressive Multifocal / diagnosis
Leukoencephalopathy, Progressive Multifocal / therapy
Magnetic Resonance Imaging
Middle Aged
Multiple Sclerosis, Relapsing-Remitting / complications
Multiple Sclerosis, Relapsing-Remitting / drug therapy
Natalizumab
Polymerase Chain Reaction
Polyomavirus Infections / diagnosis
Polyomavirus Infections / virology*
Spinal Puncture
Tumor Virus Infections / diagnosis
Tumor Virus Infections / virology*

Substances

Antibodies, Monoclonal, Humanized
DNA, Viral
Natalizumab